# info@crystallizationsummit.com
English

Office Address

  • info@crystallizationsummit.com
  • Phone: +1 732-978-0828

Pinterest

Social List

News Right Sidebar

2024 , 2024-speakers , session-2-particle-engineering-to-address-formulation-challenge

Process Development and Robust Control of Physical Attributes of an Amorphous Drug Substance

July 28, 2024
2024 , 2024-speakers , session-2-particle-engineering-to-address-formulation-challenge

Dr. Dimitrios Zarkadas, Merck & Co, USA

July 28, 2024
2024 , 2024-speakers , session-1-crystallization-of-complex-pharmaceutical-compound

Learnings from Solid Form Development of Complex HCV Drugs

July 2, 2024
2024 , 2024-speakers , session-1-crystallization-of-complex-pharmaceutical-compound

Dr. Shuang Chen, AbbVie

July 2, 2024
2024 , 2024-speakers , session-1-crystallization-of-complex-pharmaceutical-compound

Dr. Noalle Fellah, Pfizer

July 2, 2024
2024 , 2024-speakers , session-1-crystallization-of-complex-pharmaceutical-compound

Developing and optimizing a quench-crystallization operation in drug substance manufacturing

July 2, 2024
2024 , 2024-speakers , session-1-crystallization-of-complex-pharmaceutical-compound

Mr. James D. Fostinis, Amgen

July 2, 2024
2024 , 2024-speakers , session-1-crystallization-of-complex-pharmaceutical-compound

Peptide crystallisation

July 2, 2024
2024 , 2024-speakers , session-1-crystallization-of-complex-pharmaceutical-compound

Prof. Jerry Heng, Imperial College, UK

July 2, 2024
2024 , 2024-speakers , session-2-particle-engineering-to-address-formulation-challenge

Addressing poor solubility and oiling-out tendencies of drug substances

June 21, 2024
RSS
Follow by Email
Facebook
Twitter
LinkedIn
Share